Clinical Trials Directory

Trials / Completed

CompletedNCT07152899

Innovative Treatments for Neurogenic Dysphagia

New Approaches for the Treatment of Post-stroke Dysphagia and Dysphagia in Parkinson's Disease

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
110 (actual)
Sponsor
IRCCS National Neurological Institute "C. Mondino" Foundation · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

This study aims to evaluate different non-invasive and neuromuscular stimulation treatments for neurogenic dysphagia in post-stroke and Parkinson's disease patients. The study is divided into three sub-studies: 1. Unilateral, bihemispheric, or sham transcranial Direct Current Stimulation (tDCS) in post-stroke dysphagia (patients ≥2 weeks from onset). 2. Bihemispheric or sham tDCS in Parkinson's disease-related dysphagia. 3. Neuromuscular stimulation therapy in post-stroke and Parkinson's disease dysphagia.

Detailed description

Neurogenic dysphagia, commonly seen in post-stroke and Parkinson's disease patients, significantly impacts quality of life. Despite emerging treatments, there remains a lack of consensus on the best approaches for these conditions. This study evaluates three different innovative therapeutic interventions and their efficacy in improving swallowing function: Sub-study 1: Evaluates the effects of unilateral, bihemispheric, or sham tDCS applied to the swallowing motor cortex in post-stroke patients with dysphagia. Sub-study 2: Evaluates the effects of bihemispheric or sham tDCS in Parkinson's disease patients with dysphagia. Sub-study 3: Examines the effects of neuromuscular electrical stimulation (NMES) therapy on swallowing function in both post-stroke and Parkinson's disease patients. Each intervention was administered over a 6-week period with outcome measures assessed at baseline and post-treatment. All treatments were applied in conjunction with a personalized and intensive speech therapy program. This study aims to provide valuable insights into the effectiveness of tDCS and NMES as adjuncts to traditional swallowing therapy. By targeting mechanisms of brain plasticity and neuromuscular function, the study could improve treatment strategies for neurogenic dysphagia in stroke and Parkinson's disease patients. Ultimately, the findings could contribute to evidence-based guidelines for managing dysphagia in these populations. This interventional study recruited a total of 110 participants: 70 patients with post-stroke dysphagia and 40 patients with Parkinson's disease-related dysphagia. Participants were consecutively enrolled from collaborating institutions. Following informed consent, participants underwent a standardized evaluation protocol consisting of clinical and neurophysiological assessments. Swallowing function was assessed using the Dysphagia Outcome and Severity Scale (DOSS) as the primary outcome measure. Secondary outcomes include the Penetration-Aspiration Scale (PAS), Mann Assessment of Swallowing Ability (MASA), Swallowing Quality of Life Questionnaire (SWAL-QOL), and Motor Evoked Potentials (MEPs) of tongue musculature in a subgroup of participants. All stimulation interventions (tDCS or NMES) were delivered by trained clinicians according to standardized protocols. Each session was accompanied by a personalized intensive speech and swallowing therapy session, administered by certified speech-language pathologists.

Conditions

Interventions

TypeNameDescription
OTHERUnilateral anodal tDCSEvaluates the effects of unilateral, anodal tDCS applied to the swallowing motor cortex in post-stroke patients with dysphagia
OTHERBihemispheric anodal tDCSEvaluates the effects of bihemispheric, anodal tDCS applied to the swallowing motor cortex in post-stroke patients with dysphagia and in Parkinson's disease-related dysphagia
OTHERSham tDCSEvaluates the effects of Sham tDCS applied to the swallowing motor cortex in post-stroke patients with dysphagia and in Parkinson's disease-related dysphagia
OTHERNMES + swallowing therapyExamines the effects of NMES therapy on swallowing function in both post-stroke and Parkinson's disease patients
OTHERSham NMES + swallowing therapyExamines the effects of Sham therapy on swallowing function in both post-stroke and Parkinson's disease patients

Timeline

Start date
2021-06-15
Primary completion
2025-01-15
Completion
2025-05-15
First posted
2025-09-03
Last updated
2025-09-03

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT07152899. Inclusion in this directory is not an endorsement.